XML 21 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Cash Flows From Operating Activities:              
Net loss $ (497,894) $ (2,334,110) $ (387,730) $ (3,205,174) $ (2,832,004) $ (3,592,904) $ 10,000,000
Adjustments to reconcile net loss to net cash flows (used in) provided by operating activities:              
Depreciation and amortization         134,143 206,969  
Stock based compensation 376,738   585,195   688,415 1,310,393  
Provision for inventory obsolescence         238,957 371,494  
Amortization of discount on unsecured promissory notes         86,867  
Change in fair value of secured convertible notes 887,807     1,300,252  
Change in fair value of proceeds investment agreement (2,578,000)   2,961,000   (2,885,000) 3,098,000  
Provision for doubtful accounts receivable         20,000  
Debt issuance costs         34,906  
(Increase) decrease in:              
Accounts receivable - trade         (9,866) 215,840  
Accounts receivable - other         (23,620) (118,556)  
Inventories         289,170 (164,483)  
Prepaid expenses         (193,366) 135  
Operating lease right of use assets         (647,176) 224,413  
Other assets         79,981 (133,000)  
Increase (decrease) in:              
Accounts payable         (804,120) 1,073,021  
Accrued expenses         92,811 (1,018,433)  
Income taxes payable         (4,776) 244  
Operating lease obligations         572,022 (143,252)  
Contract liabilities         (174,599) (80,434)  
Net cash (used in) provided by operating activities         (4,057,003) 1,269,447  
Cash Flows from Investing Activities:              
Purchases of furniture, fixtures and equipment         (96,011) (73,705)  
Additions to intangible assets         (67,098) (26,884)  
Net cash used in investing activities         (163,109) (100,589)  
Cash Flows from Financing Activities:              
Proceeds from unsecured promissory note payable, related party         319,000  
Proceeds from unsecured promissory note payable         100,000  
Proceeds from promissory notes payable         1,568,900  
Proceeds from issuance of common stock upon exercise of warrants         5,203,122 1,564,000  
Proceeds from issuance of secured convertible notes payable         1,500,000  
Proceeds from sale of common stock in underwritten public offering         12,829,241  
Proceeds from exercise of stock options         7,800  
Principal payment on subordinated notes payable         (400,000)  
Principal payment on secured convertible notes         (748,180)  
Principal payments on unsecured promissory note payable, related party         (319,000)  
Debt issuance costs         (34,906)  
Principal payment on proceeds investment agreement         (6,000,000)  
Net cash provided by (used in) financing activities         20,025,977 (4,436,000)  
Net increase (decrease) in cash and cash equivalents         15,805,865 (3,267,142)  
Cash, cash equivalents, beginning of period   $ 359,685   $ 3,598,807 359,685 3,598,807 3,598,807
Cash, cash equivalents, end of period $ 16,165,550   $ 331,655   16,165,550 331,655 $ 359,685
Supplemental disclosures of cash flow information:              
Cash payments for interest         128,911  
Cash payments for income taxes         4,776 5,756  
Supplemental disclosures of non-cash investing and financing activities:              
Restricted common stock grant         664 522  
Restricted common stock forfeitures         36 2  
Cashless exercise of common stock purchase warrants         7  
Impact of Adoption of ASC 842 - obtaining right of use asset for lease liability         500,751  
Issuance of common stock upon conversion of secured convertible notes         3,024,685  
Amounts allocated to common stock purchase warrants in connection with issuance of unsecured promissory note payable         $ 741,947